Position in GILD
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$259,226,812
-$52,447,991 QoQ
Shares Held
2,051,819
-8.2% QoQ
Ownership
0.165%
of shares outstanding
% of Portfolio
0.20%
of 13F equity value
Holder Rank
#73
of 2,275 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 62%
Shared 0%
None 38%
Common Shares in GILD Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026RHUMBLINE ADVISERS holds $4,800,494,597 across 17 Drug Manufacturers - General names. GILD ranks #6 (5.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
1,333,307 | $1,599,208,548 | |
| 2 | JNJ |
Johnson & Johnson
|
3,780,752 | $960,197,585 | |
| 3 | ABBV |
AbbVie Inc.
|
2,733,648 | $687,895,182 | |
| 4 | MRK |
Merck & Co., Inc.
|
3,809,518 | $489,523,063 | |
| 5 | AMGN |
Amgen Inc
|
904,954 | $327,701,942 | |
| 6 | GILD |
Gilead Sciences, Inc.
This page
|
2,051,819 | $259,226,812 | |
| 7 | PFE |
Pfizer Inc
|
8,609,603 | $207,319,240 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
3,347,347 | $192,874,134 |
All Filings in GILD
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $259,226,812 | 2,051,819 | Shares | Sole | 2026-08-12 | |
| 2026-03-31 | $311,674,803 | 2,236,312 | Shares | Sole | 2026-05-12 | |
| 2025-12-31 | $278,752,236 | 2,271,079 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $258,393,126 | 2,327,866 | Shares | Sole | 2025-11-06 | |
| 2025-06-30 | $259,820,297 | 2,343,468 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $252,688,437 | 2,255,140 | Shares | Sole | 2025-05-29 | |
| 2024-12-31 | $214,631,116 | 2,323,602 | Shares | Sole | 2025-05-29 | |
| 2024-09-30 | $198,142,509 | 2,363,341 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $168,746,295 | 2,459,500 | Shares | Sole | 2024-08-01 | |
| 2024-03-31 | $180,234,408 | 2,460,538 | Shares | Sole | 2024-05-09 | |
| 2023-12-31 | $228,625,611 | 2,822,190 | Shares | Sole | 2024-02-08 | |
| 2023-09-30 | $214,486,448 | 2,862,109 | Shares | Sole | 2023-11-09 | |
| 2023-06-30 | $214,992,468 | 2,789,574 | Shares | Sole | 2023-08-08 | |
| 2023-03-31 | $231,714,467 | 2,792,750 | Shares | Sole | 2023-05-11 | |
| 2022-12-31 | $234,953,335 | 2,736,789 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $166,191,626 | 2,693,980 | Shares | Sole | 2022-11-10 | |
| 2022-06-30 | $138,831,811 | 2,246,106 | Shares | Sole | 2022-08-11 | |
| 2022-03-31 | $127,168,722 | 2,139,087 | Shares | Sole | 2022-05-12 | |
| 2021-12-31 | $152,838,604 | 2,104,925 | Shares | Sole | 2022-02-10 | |
| 2021-09-30 | $144,381,696 | 2,067,025 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $146,945,449 | 2,133,974 | Shares | Sole | 2021-08-05 | |
| 2021-03-31 | $145,930,920 | 2,257,944 | Shares | Sole | 2021-05-06 | |
| 2020-12-31 | $138,615,804 | 2,379,262 | Shares | Sole | 2021-02-10 | |
| 2020-09-30 | $158,682,664 | 2,511,199 | Shares | Sole | 2020-11-12 | |
| 2020-06-30 | $193,781,314 | 2,518,603 | Shares | Sole | 2020-08-13 | |
| 2020-03-31 | $168,001,569 | 2,247,212 | Shares | Sole | 2020-05-06 | |
| No filing history on record for this holder in this stock. | ||||||